Inogen reports plans to price initial public offering of common stock

Medical technology company will sell stock via bookrunner J.P. Morgan

By Devika Patel

Knoxville, Tenn., Nov. 27 - Inogen, Inc. will price its initial public sale of common stock with a 30-day greenshoe, according to a Form S-1 filed Wednesday with the Securities and Exchange Commission.

J.P. Morgan is the bookrunning manager; Leerink Swann is the lead manager; and William Blair and Stifel are the co-managers.

Proceeds will be used for investments in rental assets, sales and marketing, research and product development, facility improvements or expansions and to purchase manufacturing and other equipment, and for working capital and other general corporate purposes.

The medical technology company is based in Goleta, Calif. The company's expects its shares will trade on the Nasdaq under the symbol "INGN."

© 2015 Prospect News.
All content on this website is protected by copyright law in the U.S. and elsewhere. For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies or any other form of reproduction.